longbridgelongbridge
  • Platform Features
    Features
    Investment ProductsPrivate Wealth ManagementTrading ToolsMarket Data ServicesAnalysis ToolsNews ServicesFor Developers
    Account Types
    For IndividualsFor Institutions
  • Café
longbridge
© 2026 Longbridge|Terms of ServicePrivacy Policy

UnitedHealth Rally Sparks Bullish Case for Healthcare ETFs Despite Medicare Advantage Losses

benzinga_article
Jul 16, 2026 at 05:24 PM
LongbridgeAII'm LongbridgeAI, I can summarize articles.

UnitedHealth Group's stock surged 9% on raised earnings guidance and improved profitability metrics, despite losing Medicare Advantage members. This shift in investor focus from membership growth to operational efficiency has boosted major healthcare ETFs like XLV, FHLC, VHT, and IYH by approximately 2%. The positive sentiment extends to managed-care focused funds such as XHS, suggesting a broader tailwind for the sector as investors prioritize margins and cash flow over enrollment numbers.

UnitedHealth Group (NYSE:UNH) surged about 9% in premarket trading Thursday after raising its full-year earnings guidance, despite reporting a loss of 965,000 Medicare Advantage members since the end of 2025. The move suggests investors are rewarding stronger profitability rather than membership growth, a shift that could sustainably lift healthcare ETFs with heavy exposure to managed-care stocks.

The insurer reported a medical care ratio of 86.7%, down from 89.4% a year ago, while operating earnings jumped to $8 billion from $5.2 billion. It also raised its 2026 adjusted EPS guidance to $19.50-$20.00 and increased its operating cash flow outlook to around $24 billion.

Healthcare ETFs With Heavy UnitedHealth Exposure

The Health Care Select Sector SPDR Fund (NYSE:XLV) stands out as the biggest ETF beneficiary, with UnitedHealth among its largest holdings. Meanwhile, the Fidelity MSCI Health Care Index ETF (NYSE:FHLC), which carries names like Eli Lilly and Co (NYSE:LLY), Johnson & Johnson (NYSE:JNJ), and AbbVie Inc (NYSE:ABBV) aside from UnitedHealth among its top holdings, is also seeing gains.

Other diversified healthcare funds with significant exposure include the Vanguard Health Care ETF (NYSE:VHT) and the iShares U.S. Healthcare ETF (NYSE:IYH).

Each of the funds gained around 2% on Thursday. A rebound in UnitedHealth could provide a tailwind for these ETFs, particularly after the stock had weighed on healthcare sector performance earlier this year.

Managed-Care ETFs Could See Broader Gains

The earnings report also strengthens the outlook for managed-care peers. The positive earnings surprise could also support ETFs with greater exposure to health insurers. The SPDR S&P Health Care Services ETF (NYSE:XHS) allocates a significant portion of its portfolio to managed-care companies, including UnitedHealth, Elevance Health Inc (NYSE:ELV), Cigna Group (NYSE:CI), Humana Inc (NYSE:HUM), and CVS Health Corp (NYSE:CVS), making it one of the more direct ETF plays on improving insurer fundamentals. The fund rose close to 2% Thursday morning.

Broader healthcare funds such as XLV, VHT, and IYH also hold these insurers among their top positions. If investors continue rewarding pricing discipline, lower medical costs and stronger cash generation over Medicare Advantage enrollment growth, the improved sentiment could extend across the managed-care industry, providing a tailwind for these ETFs.

A New Investment Narrative

UnitedHealth’s quarter challenges the long-held view that Medicare Advantage membership is the primary driver of insurer valuations. Instead, the company’s improved margins, higher earnings and stronger cash generation indicate that operational efficiency is becoming the more closely watched metric.

If this trend persists, healthcare ETFs with diversified exposure to managed-care leaders could benefit as investors increasingly favor profitability over membership growth.

Read Also: SpaceX Just Landed in a Very Strange Place — Inside Value ETFs

Photo: Piotr Swat / Shutterstock

Login to unlock2,590characters for free

Due to copyright restrictions, please log in to your Longbridge account to view this content.
Thank you for your understanding and support of licensed content.

Recommended Readings

  • Apr 20, 2026 at 06:34 PMEli Lilly Announces $7 Billion Acquisition of Kelonia: Pioneering the 'In Vivo CAR-T' Frontier and Leading Gene Therapy …
  • Apr 7, 2026 at 10:32 PMReminder: Key events to watch intraday (all times Beijing Time)
  • Apr 1, 2026 at 11:11 PMEli Lilly's Oral Weight-Loss Drug Foundayo Approved, the Only One That Can Be Taken Anytime Without Fasting
  • Mar 9, 2026 at 04:15 PMHandshake and reconciliation! Novo Nordisk withdraws lawsuit, Wegovy officially launches on the Hims & Hers platform
  • Feb 26, 2026 at 12:54 PMBeigene's Q4 revenue increased by 33% year-on-year, turning a profit for the full year, with Baiyueze achieving a record…

Related Stocks

Unitedhealth

Unitedhealth

USUNH

+2.25%

Eli Lilly

Eli Lilly

USLLY

Abbvie

Abbvie

USABBV

LongbridgeAI